Instituto de Investigación Biomédica de A Coruña (INIBIC)
Research center
University of Manchester
Mánchester, Reino UnidoPublications in collaboration with researchers from University of Manchester (131)
2024
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease: a secondary analysis from MARIPOSA
Annals of Oncology, Vol. 35, Núm. 9, pp. 805-816
2023
-
A foundation model for generalizable disease detection from retinal images
Nature, Vol. 622, Núm. 7981, pp. 156-163
2022
-
An aphasia research agenda–a consensus statement from the collaboration of aphasia trialists
Aphasiology, Vol. 36, Núm. 4, pp. 555-574
-
Efficacy and Safety of Brigatinib Compared With Crizotinib in Asian vs. Non-Asian Patients With Locally Advanced or Metastatic ALK–Inhibitor-Naive ALK+ Non–Small Cell Lung Cancer: Final Results From the Phase III ALTA-1L Study
Clinical Lung Cancer, Vol. 23, Núm. 8, pp. 720-730
-
The value of disease-free survival (DFS) and osimertinib in adjuvant non-small-cell lung cancer (NSCLC): an international Delphi consensus report
ESMO Open, Vol. 7, Núm. 5
2021
-
Algorithmic assessment of cellular senescence in experimental and clinical specimens
Nature Protocols, Vol. 16, Núm. 5, pp. 2471-2498
-
Brigatinib Versus Crizotinib in ALK Inhibitor–Naive Advanced ALK-Positive NSCLC: Final Results of Phase 3 ALTA-1L Trial
Journal of Thoracic Oncology, Vol. 16, Núm. 12, pp. 2091-2108
-
Physiological hypoxia restrains the senescence-associated secretory phenotype via AMPK-mediated mTOR suppression
Molecular Cell, Vol. 81, Núm. 9, pp. 2041-2052.e6
2020
2019
-
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
Nature Communications, Vol. 10, Núm. 1
-
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Nature Communications, Vol. 10, Núm. 1
-
Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature
Reumatologia Clinica, Vol. 15, Núm. 1, pp. 34-42
2018
-
Progress of the attractiveness of Rheumatology among medical speciality training candidates (MIR) in Spain
Reumatologia Clinica, Vol. 14, Núm. 3, pp. 150-154
-
Sensing Uranyl(VI) Ions by Coordination and Energy Transfer to a Luminescent Europium(III) Complex
Angewandte Chemie - International Edition, Vol. 57, Núm. 31, pp. 9921-9924
-
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: Results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis
Rheumatology (United Kingdom), Vol. 57, Núm. 9, pp. 1533-1540
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
-
Cannabis, Endocannabinoid CB1 Receptors, and the Neuropathology of Vision
Neuropathology of Drug Addictions and Substance Misuse (Elsevier Inc.), pp. 738-748
-
Cannabis, Endocannabinoid CB1 Receptors, and the Neuropathology of Vision
Neuropathology of Drug Addictions and Substance Misuse Volume 1: Foundations of Understanding, Tobacco, Alcohol, Cannabinoids and Opioids (Elsevier), pp. 738-748
-
Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356
Autophagy
-
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
Autophagy, Vol. 12, Núm. 1, pp. 1-222